Transgene S.A.

Transgene S.A. - PE Ratioverified

TRGNF

Price:

$0.85

Market Cap:

$108.44M

Transgene S.A. is a biotechnology company dedicated to the creation and advancement of therapeutic vaccines and oncolytic viruses. Its core mission is to develop innovative treatments for both cancer and various infectious diseases. The company's drug development pipeline includes several promising candidates: TG4050, a therapeutic vaccine, is currently in early-stage Phase I clinical trials for its potential use against ovarian cancer and certain types of HPV-negative head and neck cancers. TG4001, another therapeutic vaccine, has progressed to Phase II clinical trials, where it is being evaluated for the treatment of HPV-positive cancers. TG6002, an oncolytic virus, is undergoing Phase I/I...[Read more]

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

TRGNF

The PE Ratio as of June 2026 (TTM) for Transgene S.A. (TRGNF) is -2.83

According to Transgene S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -2.83. This represents a change of 73.91% compared to the average of -1.63 of the last 4 quarters.

Transgene S.A. (TRGNF) Historical PE Ratio (quarterly & annually)

How has TRGNF PE Ratio performed in the past?

The mean historical PE Ratio of Transgene S.A. over the last ten years is -3.39. The current -2.83 PE Ratio has changed 8.26% with respect to the historical average. Over the past ten years (40 quarters), TRGNF's PE Ratio was at its highest in in the December 2018 quarter at 1.75. The PE Ratio was at its lowest in in the June 2007 quarter at -35.54.

Quarterly (TTM)
Annual

Average

-3.39

Median

-5.65

Minimum

-11.55

Maximum

20.48

Transgene S.A. (TRGNF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Transgene S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 178.08%

Maximum Annual PE Ratio = 20.48

Minimum Annual Increase = -473.17%

Minimum Annual PE Ratio = -11.55

Quarterly (TTM)
Annual
YearPE RatioChange
2025-3.6957.47%
2024-2.34-62.35%
2023-6.2323.94%
2022-5.02-56.48%
2021-11.5554.13%
2020-7.4911.16%
2019-6.74-132.91%
201820.48-473.17%
2017-5.49-5.51%
2016-5.81178.08%

Transgene S.A. (TRGNF) Average PE Ratio

How has TRGNF PE Ratio performed in the past?

The current PE Ratio of Transgene S.A. (TRGNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.09

5-year avg

-5.77

10-year avg

-3.39

Transgene S.A. (TRGNF) PE Ratio vs. Peers

How is TRGNF’s PE Ratio compared to its peers?

Transgene S.A.’s PE Ratio is greater than Hansa Biopharma AB (publ) (-4.11), less than Silence Therapeutics plc (-1.60), greater than Cellectis S.A. (-4.55), less than Immutep Limited (-0.92), greater than Genfit S.A. (-6.20), greater than hVIVO plc (-8.92), greater than Santhera Pharmaceuticals Holding AG (-4.17), less than Mayne Pharma Group Limited (-2.19), less than Probi AB (publ) (235.75), greater than Oryzon Genomics S.A. (-112.81),

Build a custom stock screener for Transgene S.A. (TRGNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Transgene S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Transgene S.A. (TRGNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Transgene S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Transgene S.A.'s PE Ratio?

How is the PE Ratio calculated for Transgene S.A. (TRGNF)?

What is the highest PE Ratio for Transgene S.A. (TRGNF)?

What is the 3-year average PE Ratio for Transgene S.A. (TRGNF)?

What is the 5-year average PE Ratio for Transgene S.A. (TRGNF)?

How does the current PE Ratio for Transgene S.A. (TRGNF) compare to its historical average?